Pelin Şenol

Dr. Pelin Şenol


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
EYEmine Nur Sunar Yayla
Emine Nur Sunar Yayla
ÇYÇisem Yıldız
Çisem Yıldız
PŞPelin Şenol
Pelin Şenol
NKNihal Karaçayır
Nihal Karaçayır
DYDeniz Gezgin Yıldırım
Deniz Gezgin Yıldırım
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU
Adverse events,biological treatments,pediatric rheumatology

23 September 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
DYDeniz Gezgin Yıldırım
Deniz Gezgin Yıldırım
ÇYÇisem Yıldız Yıldırım
Çisem Yıldız Yıldırım
NKNihal Karaçayır
Nihal Karaçayır
PŞPelin Şenol
Pelin Şenol
EYEmine Nur Sunar Yayla
Emine Nur Sunar Yayla
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU

1 January 2023 in Pediatrics International
Verified
Journal Article
Closed access
HEHatice Kubra Erkilet
Hatice Kubra Erkilet
DYDeniz Gezgin Yildirim
Deniz Gezgin Yildirim
PŞPelin Şenol
Pelin Şenol
OSOğuz Söylemezoğlu
Oğuz Söylemezoğlu

19 March 2025 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ÇYÇisem Yıldız
Çisem Yıldız
BKBatuhan Küçükali
Batuhan Küçükali
MKMerve Kutlar
Merve Kutlar
NBNuran Belder
Nuran Belder
NKNihal Karaçayır
Nihal Karaçayır
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU
Juvenile idiopathic arthritis (JIA) presents with diverse phenotypes and can lead to significant morbidity. Obesity, affecting 5 to 23% of JIA patients, may exacerbate disease activity and complicate management. This study evaluates the impact of body mass index (BMI) on disease activity and the influence of joint involvement on BMI in JIA patients. Between January 2012 and June 2024, 225 JIA patients were reviewed, with 173 ultimately included based on specific inclusion and exclusion criteria. Treatments followed the American College of Rheumatology (ACR) recommendations. Data on demographics, BMI, JADAS-27 scores, joint involvement, and laboratory parameters were analyzed, with statistical significance defined as p < 0.05. Among 173 JIA patients, significant increases in weight and height SDS were observed (p < 0.05). Obese patients at baseline had higher JADAS-27 scores at 6 months (p < 0.05). A positive correlation was found between initial JADAS-27 and final BMI SDS (r = 0.170, p < 0.05). Patients with hip involvement had lower BMI at diagnosis and at the first-year follow-up (p < 0.0001, p = 0.049), while knee involvement was linked to lower height SDS at the second year (p = 0.041). Conclusion: Our study revealed that baseline obesity is a significant risk factor for poorer disease control at the 6-month follow-up in JIA patients. We also observed that effective treatment led to improvements in growth, particularly in patients with hip involvement, who initially had lower BMI values. These findings underscore the importance of monitoring BMI in JIA patients to optimize disease management and long-term outcomes. What is Known:• Overweight and obesity are prevalent in children with JIA, with reported rates ranging from 5 to 23% in various studies.• The relationship between BMI and disease activity in JIA remains controversial, with previous studies reporting conflicting results on whether BMI impacts disease remission or activity. What is New:• Baseline obesity in juvenile idiopathic arthritis (JIA) patients is associated with worse disease activity during follow-up, particularly evident at the 6-month visit.• Patients with hip involvement had significantly lower BMI values, indicating a potential correlation with more severe disease.• Improved linear growth was observed in JIA patients during follow-up, indicating that effective treatment positively impacts growth despite the chronic nature of the disease.

17 October 2023 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
BKBatuhan Küçükali
Batuhan Küçükali
DYDeniz Gezgin Yıldırım
Deniz Gezgin Yıldırım
PŞPelin Şenol
Pelin Şenol
HOHuseyin Baran Ozdemir
Huseyin Baran Ozdemir
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU

14 October 2024 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ÇYÇisem Yıldız
Çisem Yıldız
BKBatuhan Küçükali
Batuhan Küçükali
SCSushma Shree B. C.
Sushma Shree B. C.
PŞPelin Şenol
Pelin Şenol
MKMerve Kutlar
Merve Kutlar
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU